皮表皮生长因子受体 (EGFR) 抑制剂从自动显示的Fv-抗体库中选

Jeong Soo Sung1, Jaeyong Jung1, Tae-Hun Kim1

  • 1Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul 03722, Republic of Korea.

Bioconjugate chemistry
|August 28, 2024
PubMed
概括

研究人员选了Fv-抗体库,以确定表皮生长因子受体 (EGFR) 的抑制剂. 确定了针对EGFR的两种新型Fv抗体,通过降低瘤细胞活力来显示癌症治疗的潜力.